Dentsply Intl Inc: (NASD: XRAY)

$42.31

0.13 (0.31%)

Volume 905,785

May 21 04:00 PM ET

Zacks Rank: 4-Sell

Zacks Rank	Definition	Annualized Return
#1	Strong Buy	26.6%
#2	Buy	18.71%
#3	Hold	10.12%
#4	Sell	4.32%
#5	Strong Sell	2.16%
S&P	500	9.93%

Overview Quote

            Stock Activity
        
		Day Low - High
		42.03 - 42.38
	
		52wk Low - High
		35.04 - 44.21
	
		Previous Close
		42.18
	
		Avg. Volume
		852,523
	
		Industry
		MED/DENTAL-SUPP
	
		Market Cap
		6.03 B
	
		Div - Yield
		0.25 - 0.59
	
		Beta
		1.16
	
		PE (Forward)
		17.72
	
		Current Year Est.
		2.38
	
		Quarterly Earnings ESP 
		0.00%
	
Earnings ESP (Expected Surprise Prediction) is Zacks' proprietary methodology for determining which stocks have the best chance to surprise with their next earnings announcement. The Earnings ESP shows the percentage difference between the Most Accurate Estimate and the Consensus.

                Premium research
            
		Zacks Rank  Short-Term: 1-3 Months
                                                                
                                                                Zacks #1 Rank Strong Buys
                                                                
                                                            This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below. 

                                                                        Zacks Rank
                                                                        Definition
                                                                        Annualized Return
                                                                    
                                                                        #1
                                                                        Strong Buy
                                                                        26.6%
                                                                    
                                                                        #2
                                                                        Buy
                                                                        18.71%
                                                                    
                                                                        #3
                                                                        Hold
                                                                        10.12%
                                                                    
                                                                        #4
                                                                        Sell
                                                                        4.32%
                                                                    
                                                                        #5
                                                                        Strong Sell
                                                                        2.16%
                                                                    
                                                                        S&P
                                                                        500
                                                                        9.93%
                                                                    
Zacks Rank Education - Learn more about the Zacks Rank
Zacks Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank
                                                        
		4
Sell

		Zacks Recommendation  Long-Term: 6+ Months
                                                                
                                                                All Outperform Rated Stocks
                                                                
                                                            Zacks Recommendations are an excellent predictor of stock price movement over a 6+ month time frame. The recommendations come from the Zacks Equity Research group which combines the Zacks Rank with the insights from their team of over 50 equity analysts. The result is superior long term stock ratings.
The Zacks Recommendations are split into 3 groups: Buy, Hold and Sell. Our Buy recommendations have generated returns of 34.4% in 2006, and 16.69% in 2007. When Zacks Premium members click on the recommendation it will launch them to the Zacks Equity Research report for the stock.    More on these reports below.

                                                                    Difference Between Zacks Rank and Zacks Recommendation

                                                                    Zacks Equity Research Home
Zacks Premium - The only way to get access to Zacks Recommendations
                                                                
		Neutral
	
		Zacks Industry Rank Which industries are set to outperform or underperform the market? You'll find the answer here. We have broken down all industries into over 200 classifications. Then ranked these industries using the most powerful indicator we know (the Zacks Rank). The higher the industry rank, the better the industry should perform in the future. Once you have found an attractive industry then check out the Rank in Industry to find the best stocks within the industry.
When Zacks Premium members click on the Zacks Industry Rank link they will see the full listing of industries and their current rankings.

                                                                About Zacks Industry Rank

                                                                Zacks Industry Rank - All current industry ranks. 

                                                                Zacks Premium - The only way to get access to the Zacks Industry Rank
                                                            
		114 out of 265
	
		Equity Research Report The Zacks Recommendations and Zacks Target Prices are just two of the valuable resources you'll find in the reports created by the Zacks Equity Research group. When Zacks Premium members click on this link they will taken to a page that gives them access to the Zacks Equity Research report for the stock.

                                        Zacks Equity Research Home
                                        Zacks Premium - The only way to get access to Zacks Recommendations
                                    
Updated as of 05/10/2013

		PREMIUM
	
    (  = Change in last 30 days) 
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium Start Free Trial 
Zacks Premium Home | Zacks Rank Stock Education

                Key Earnings Data
            
                            PE (Forward)
                            17.72
                        
                            PEG Ratio
                            1.65
                        
                            Current Year Est.
                            2.38
                        
                            Current Quarter Estimate
                            0.65
                        
                            Most Accurate Estimate
                            0.65
                        
                            Earnings ESP 
                            0.00%
                        
                            Next Earnings Report Date
                            08-06-2013
                        
                            EPS Last Year
                            2.21
                        
                            Expected Earnings Growth
                            10.75%
                        
Earnings ESP (Expected Surprise Prediction) is Zacks' proprietary methodology for determining which stocks have the best chance to surprise with their next earnings announcement. The Earnings ESP shows the percentage difference between the Most Accurate Estimate and the Consensus.

            Company Description
        
DENTSPLY International Inc. designs, develops, manufactures and markets products in two principal categories: dental consumable and laboratory products, and dental equipment.  Dental consumable and laboratory products include dental prosthetics, endodontic instruments and materials, impression materials, restorative materials, crown and bridge materials, prophylaxis paste, dental sealants, cutting instruments, dental needles, dental anesthetics, and orthodontic appliances.   
Full XRAY Company Report

        
NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.

            Interactive Java Charting | Fundamental Charts
        
            <a href="#"><img id="dart_image_1" src="http://b7d61a7c6b8c307bf531-a92a66b9587e2a0aa805bd4e70b98407.r95.cf2.rackcdn.com/images/zacks/logos/zacks_logo_230x76.png" width="336" height="280" border="0" alt="" /></a>        
Turn Earnings Surprises into quick profits.
 
XRAY Chart  by YCharts

Earnings Estimates

	Current Qtr (06/2013)	Next Qtr (09/2013)	Current Year (12/2013)	Next Year (12/2014)
Average Estimate	0.65	0.58	2.38	2.62
Number of Estimates	10	9	11	10
Low Estimate	0.60	0.55	2.33	2.52
High Estimate	0.68	0.61	2.42	NA
Year Ago EPS	0.62	0.51	2.22	2.38
EPS Growth	4.52%	13.29%	7.21%	10.25%

More XRAY Estimates

Average Earnings Estimates for XRAY

EPS Growth for XRAY

Industry Analysis

Name	Symbol	Previous Close
DENTSPLY INTL	XRAY	42.18
LUXOTTICA ADR	LUX	52.91
ALPHATEC HLDGS	ATEC	1.92
BECTON DICKINSO	BDX	101.12
CONMED CORP	CNMD	33.76
COOPER COS	COO	111.07
STERIS CORP	STE	46.12
WEST PHARM SVC	WST	68.74
ALIGN TECH INC	ALGN	37.80
BARD C R INC	BCR	106.97

Sector:Medical>> Industry:MED/DENTAL-SUPP

COMPARE TICKER vs. Its Peers

Zacks Commentary

DENTSPLY Misses Earnings Est; Outlook Down

May 09, 2013

Will DENTSPLY Beat Earnings in 1Q?

May 08, 2013

Pharma & Biotech Stock Outlook - Apr 2013

Apr, 04 2013 00:00

Pharma & Biotech Stock Outlook - Apr 2013

Apr, 04 2013 00:00

Reiterate DENTSPLY at Neutral

Apr 03, 2013

DENTSPLY Boosts Dividend by 13.6%

Feb 27, 2013

Dentsply Beats Squarely, Profit Up

Feb 20, 2013

DENTSPLY Likely to Beat 4Q Earnings

Feb 19, 2013

More XRAY Zacks Commentary

Financials

EPS TTM	2.21
Sales	2,928
Net Income	333
Price/Earnings	19.09
Price/Book	2.66
Price/Cash Flow	13.14
Price/Sales	2.05

More XRAY Financials

News

Alere is Among the Companies in the Health Care Supplies Industry With the Highest Forward Earnings Yield (ALR, XRAY, UTMD) - Financial News Network Online - News Corner

May 21, 2013

Downgrade Alert for DENTSPLY International (XRAY) - Comtex Smartrend(R)

May 21, 2013

UPDATE: Barrington Downgrades DENTSPLY to Market Perform Awaiting More Attractive Entry Point - Benzinga

May 21, 2013

Post Earnings Update: DENTSPLY International Has Sunk 0.4% Lower in Past Week (XRAY) - Comtex Smartrend(R)

May 20, 2013

Potential Dentsply International (XRAY) Trade Has $39.08 Breakeven - Freshbrewedmedia

May 20, 2013

DENTSPLY International Earnings Review: 9 Days after Announcement Shares Down 0.4% (XRAY) - Financial News Network Online - Earnings Lookback

May 18, 2013

DENTSPLY International Inc. to Present at the UBS Global Healthcare Conference - Thomson Reuters One

May 17, 2013

DENTSPLY International Inc. to Present at the Bank of America Merrill Lynch 2013 Healthcare Conference - Thomson Reuters One

May 13, 2013

See All News Stories on XRAY

Broker Recommendations

Current ABR	2.27
ABR (Last Week)	2.27
# of recs in ABR	11
Average Target Price	43.00
Industry Rank by ABR	114 out of 265
Rank in Industry	24 out of 29

More XRAY Broker Recommendations

Day Low - High	42.03 - 42.38
52wk Low - High	35.04 - 44.21
Previous Close	42.18
Avg. Volume	852,523
Industry	MED/DENTAL-SUPP
Market Cap	6.03 B
Div - Yield	0.25 - 0.59
Beta	1.16
PE (Forward)	17.72
Current Year Est.	2.38
Quarterly Earnings ESP	0.00%

PE (Forward)	17.72
PEG Ratio	1.65
Current Year Est.	2.38
Current Quarter Estimate	0.65
Most Accurate Estimate	0.65
Earnings ESP	0.00%
Next Earnings Report Date	08-06-2013
EPS Last Year	2.21
Expected Earnings Growth	10.75%

Username: Password:

Remember me [?]

Dentsply Intl Inc: (NASD: XRAY)

$42.31

0.13 (0.31%)

Volume 905,785

May 21 04:00 PM ET

Stock Activity

Premium research

Zacks Rank Short-Term: 1-3 Months

Zacks Recommendation Long-Term: 6+ Months

Zacks Industry Rank

Equity Research Report

Key Earnings Data

Company Description

Earnings Estimates

Industry Analysis

Sector:Medical>> Industry:MED/DENTAL-SUPP

Zacks Commentary

Financials

News

Broker Recommendations